Upregulation of thrombospondin-1 and angiogenesis in an aggressive human pancreatic cancer cell line selected for high metastasis

Michele K. McElroy, Sharmeela Kaushal, Hop S. Tran Cao, A. R. Moossa, Mark A. Talamini, Robert M. Hoffman, Michael Bouvet

Research output: Contribution to journalArticle

Abstract

Pancreatic cancer remains a leading cause of death despite its relatively low incidence. As in many other solid tumors, angiogenesis is critical to the growth and metastasis of this cancer. Through serial in vivo passages in mice, we have developed a highly aggressive variant of human pancreatic cancer cell line XPA-1 which shows more rapid primary tumor growth, faster time to metastasis, and more rapid lethality than the parental cell line. The high-metastatic variant developed a much denser tumor vasculature early during growth within the pancreas. Interestingly, examination of the in vitro growth of this aggressive variant yielded no significant difference from the parental cell line. Real-time PCR evaluation of genes involved in angiogenesis revealed a 24-fold increase in Thrombospondin-1 expression in cells derived from the high-metastatic variant when compared with the parental cell line. These findings provide direct evidence that elevated capability for angiogenesis, mediated by specific changes in gene expression, can lead to a large increase in cancer aggressiveness and resulting metastasis. These findings have important implications for the treatment of metastatic disease.

Original languageEnglish (US)
Pages (from-to)1779-1786
Number of pages8
JournalMolecular Cancer Therapeutics
Volume8
Issue number7
DOIs
StatePublished - Jul 1 2009
Externally publishedYes

Fingerprint

Thrombospondin 1
Pancreatic Neoplasms
Up-Regulation
Neoplasm Metastasis
Cell Line
Neoplasms
Growth
Real-Time Polymerase Chain Reaction
Pancreas
Cause of Death
Gene Expression
Incidence
Genes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

McElroy, M. K., Kaushal, S., Tran Cao, H. S., Moossa, A. R., Talamini, M. A., Hoffman, R. M., & Bouvet, M. (2009). Upregulation of thrombospondin-1 and angiogenesis in an aggressive human pancreatic cancer cell line selected for high metastasis. Molecular Cancer Therapeutics, 8(7), 1779-1786. https://doi.org/10.1158/1535-7163.MCT-09-0122

Upregulation of thrombospondin-1 and angiogenesis in an aggressive human pancreatic cancer cell line selected for high metastasis. / McElroy, Michele K.; Kaushal, Sharmeela; Tran Cao, Hop S.; Moossa, A. R.; Talamini, Mark A.; Hoffman, Robert M.; Bouvet, Michael.

In: Molecular Cancer Therapeutics, Vol. 8, No. 7, 01.07.2009, p. 1779-1786.

Research output: Contribution to journalArticle

McElroy, Michele K. ; Kaushal, Sharmeela ; Tran Cao, Hop S. ; Moossa, A. R. ; Talamini, Mark A. ; Hoffman, Robert M. ; Bouvet, Michael. / Upregulation of thrombospondin-1 and angiogenesis in an aggressive human pancreatic cancer cell line selected for high metastasis. In: Molecular Cancer Therapeutics. 2009 ; Vol. 8, No. 7. pp. 1779-1786.
@article{8ad4d868cc6b4d278b8f2846a5560f00,
title = "Upregulation of thrombospondin-1 and angiogenesis in an aggressive human pancreatic cancer cell line selected for high metastasis",
abstract = "Pancreatic cancer remains a leading cause of death despite its relatively low incidence. As in many other solid tumors, angiogenesis is critical to the growth and metastasis of this cancer. Through serial in vivo passages in mice, we have developed a highly aggressive variant of human pancreatic cancer cell line XPA-1 which shows more rapid primary tumor growth, faster time to metastasis, and more rapid lethality than the parental cell line. The high-metastatic variant developed a much denser tumor vasculature early during growth within the pancreas. Interestingly, examination of the in vitro growth of this aggressive variant yielded no significant difference from the parental cell line. Real-time PCR evaluation of genes involved in angiogenesis revealed a 24-fold increase in Thrombospondin-1 expression in cells derived from the high-metastatic variant when compared with the parental cell line. These findings provide direct evidence that elevated capability for angiogenesis, mediated by specific changes in gene expression, can lead to a large increase in cancer aggressiveness and resulting metastasis. These findings have important implications for the treatment of metastatic disease.",
author = "McElroy, {Michele K.} and Sharmeela Kaushal and {Tran Cao}, {Hop S.} and Moossa, {A. R.} and Talamini, {Mark A.} and Hoffman, {Robert M.} and Michael Bouvet",
year = "2009",
month = "7",
day = "1",
doi = "10.1158/1535-7163.MCT-09-0122",
language = "English (US)",
volume = "8",
pages = "1779--1786",
journal = "Molecular Cancer Therapeutics",
issn = "1535-7163",
publisher = "American Association for Cancer Research Inc.",
number = "7",

}

TY - JOUR

T1 - Upregulation of thrombospondin-1 and angiogenesis in an aggressive human pancreatic cancer cell line selected for high metastasis

AU - McElroy, Michele K.

AU - Kaushal, Sharmeela

AU - Tran Cao, Hop S.

AU - Moossa, A. R.

AU - Talamini, Mark A.

AU - Hoffman, Robert M.

AU - Bouvet, Michael

PY - 2009/7/1

Y1 - 2009/7/1

N2 - Pancreatic cancer remains a leading cause of death despite its relatively low incidence. As in many other solid tumors, angiogenesis is critical to the growth and metastasis of this cancer. Through serial in vivo passages in mice, we have developed a highly aggressive variant of human pancreatic cancer cell line XPA-1 which shows more rapid primary tumor growth, faster time to metastasis, and more rapid lethality than the parental cell line. The high-metastatic variant developed a much denser tumor vasculature early during growth within the pancreas. Interestingly, examination of the in vitro growth of this aggressive variant yielded no significant difference from the parental cell line. Real-time PCR evaluation of genes involved in angiogenesis revealed a 24-fold increase in Thrombospondin-1 expression in cells derived from the high-metastatic variant when compared with the parental cell line. These findings provide direct evidence that elevated capability for angiogenesis, mediated by specific changes in gene expression, can lead to a large increase in cancer aggressiveness and resulting metastasis. These findings have important implications for the treatment of metastatic disease.

AB - Pancreatic cancer remains a leading cause of death despite its relatively low incidence. As in many other solid tumors, angiogenesis is critical to the growth and metastasis of this cancer. Through serial in vivo passages in mice, we have developed a highly aggressive variant of human pancreatic cancer cell line XPA-1 which shows more rapid primary tumor growth, faster time to metastasis, and more rapid lethality than the parental cell line. The high-metastatic variant developed a much denser tumor vasculature early during growth within the pancreas. Interestingly, examination of the in vitro growth of this aggressive variant yielded no significant difference from the parental cell line. Real-time PCR evaluation of genes involved in angiogenesis revealed a 24-fold increase in Thrombospondin-1 expression in cells derived from the high-metastatic variant when compared with the parental cell line. These findings provide direct evidence that elevated capability for angiogenesis, mediated by specific changes in gene expression, can lead to a large increase in cancer aggressiveness and resulting metastasis. These findings have important implications for the treatment of metastatic disease.

UR - http://www.scopus.com/inward/record.url?scp=67651146532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67651146532&partnerID=8YFLogxK

U2 - 10.1158/1535-7163.MCT-09-0122

DO - 10.1158/1535-7163.MCT-09-0122

M3 - Article

C2 - 19584238

AN - SCOPUS:67651146532

VL - 8

SP - 1779

EP - 1786

JO - Molecular Cancer Therapeutics

JF - Molecular Cancer Therapeutics

SN - 1535-7163

IS - 7

ER -